Back to top

2007 Supplementary Materials for Manuscripts

  • Jia et al., 2007 Foodborne Pathogens and Disease 4:222-232
  • Nightingale et al., 2007; J. Food Prot. 70:482-488
    ​K. K. Nightingale*, S. R. Milillo, R. A. Ivy, A. J. Ho, H. F. Oliver, and M. Wiedmann 2006. Appl. Enviro.Microbiol Listeria monocytogenes F2365 is characterized by an elevated frequency of truncated genes, including inlB, and by unique phenotypic characteristics that limit its appeal to represent human outbreak associated strains.
  • Nightingale et al., 2007, J. Microbiol. Meth. 68:52-59
    Kendra Nightingale, Liselle Bovell, Ashley Grajczyk, and Martin Wiedmann. 2006. Combined DNA sequencing and multiplex PCR provides a good alternative to conventional serotyping of Listeria monocytogenes isolates and differentiates serotype 4b isolates belonging to lineages I and III. J. Microbiol. Meth.
  • Fugett et al., 2007. J. Clin. Microbiol. 45:865-873
    Fugett, E. B., D. Schoonmaker-Bopp, N. B. Dumas, J. Corby, and M. Wiedmann. 2006. Pulsed-field gel electrophoresis analysis of temporally matched Listeria monocytogenes isolates from human clinical cases, foods, ruminant farms, and urban and natural environments reveals source associated as well as widely distributed PFGE types. J. Clin. Micro. (in preparation)
    • Supplemental Table ST1  Listeria monocytogenes isolates.
    • Supplemental Figure S1.     Geospatial and source distributions of PFGE types occurring at least 5 times. Source abbreviations are as follows: H, human; Fd, food; Fm, farm; E, environmental. All foods except those denoted with an asterisk (*) are ready-to-eat. Dates of isolation are given as month/year.
  • Chan et al. 2007. J. Food Prot. 71:420-5 Y. C. Chan, Y. Hu, S. Chaturongakul, K. D. Files, B. M. Bowen, K. J. Boor, and M. Wiedmann.  2007.  Contributions of Two Component Regulatory Systems, Alternative σ Factors, and Negative Regulators to L. monocytogenes Growth at Low Temperature.  J. Food Prot. (submitted)
    • Supplemental Table S1.  Primers used for generation of null mutants not reported in published manuscripts.
    • Supplemental Figure S1.  Growth of L. monocytogenes strain 10403S and null mutants between 0 and 12 days at 4°C using a starting inoculum of 10^8 CFU/mL. 
    • Supplemental Figure S2. Growth in BHI over 12 days at 4°C of L. monocytogenes strain 10403S and selected null mutant strains, using a starting inoculum of 10^8 CFU/ml. 
    • Supplemental Figure S3.  Growth in BHI over 84 days at 4°C of L. monocytogenes strain 10403S and selected null mutant strains using a starting inoculum of 10^2 CFU/mL. 
    • Supplemental Figure S4.  Growth in BHI over 12 days at 4°C of cold-adapted L. monocytogenes strain 10403S and selected null mutants, using a starting inoculum of 10^8 CFU/ml.